UK Patents Court Finds Sustained-Release Quetiapine Patent Invalid, by Darren Smyth

No items found.
​
19 June 2012
Tags
Life
Patent Strategy
Table of contents
  • Toc Heading
  • Toc Heading

Partner Darren Smyth has had an article on the Seroquel case published on the website of the Controlled Release Society.

The regular ‘Inside Track’ feature provides insider knowledge on recent developments in the science and technology of controlled release.

Darren’s article outlines the background to a case involving AstraZeneca's patent for the sustained release formulation of quetiapine, marketed under the brand name Seroquel. He looks at the reasons for two differing judgements and implications for IP strategy to protect sustained release products.

Related articles

See all articles

EIP welcomes Anders Hansson as Partner to further strengthen our digital practice
19 January 2026
EIP is pleased to welcome Anders Hansson as Partner, bringing nearly 20 years of experience in AI, robotics, digital technologies, and European patent strategy. His industry and private‑practice background further strengthens our digital and high‑tech capabilities across Europe.
​
EIP Launches Tech & AI Function to Drive Innovation and Client Excellence
06 November 2025
When it comes to technology, EIP has always been ahead of the curve; we are proud to announce the evolution of our IT department into a dedicated Tech & AI function, marking a bold step towards...
​
Trade Secrets: Navigating geopolitical risks and IP theft in the semiconductor industry
04 November 2025
Semiconductors have always been a critical technology but have grown significantly in strategic importance in recent years. They have become the key building block in developing and existing markets, including quantum computing, edge computing, AI, IoT, automotive, cellular data technology, smartphones, robotics, and many more. The complex designs and innovations that power semiconductor manufacturing are invaluable both to the world’s economy and technological advancement. Consequently, the semiconductor industry has found itself at the centre of geopolitical tensions, especially between the United States and China. It has become a prime target for cyberattacks and intellectual-property (IP) theft. As such, companies operating in this area must be more vigilant in protecting their intellectual assets.
​